Symbol="VIRX"
AssetType="Common Stock"
Name="Viracta Therapeutics Inc"
Description="Viracta Therapeutics, Inc., a precision oncology company, is dedicated to developing drugs for the treatment of virus-associated malignancies. The company is headquartered in Cardiff-by-the-Sea, California."
CIK="1061027"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="54398000"
EBITDA="-53966000"
PERatio="None"
PEGRatio="None"
BookValue="0.916"
DividendPerShare="0"
DividendYield="0"
EPS="-1.34"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.409"
ReturnOnEquityTTM="-0.896"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.182"
EVToRevenue="-"
EVToEBITDA="-0.148"
Beta="-0.174"
num_52WeekHigh="5.75"
num_52WeekLow="0.88"
num_50DayMovingAverage="1.435"
num_200DayMovingAverage="1.679"
SharesOutstanding="38580400"
DividendDate="2020-09-03"
ExDividendDate="None"
symbol="VIRX"
open="1.42"
high="1.44"
low="1.40"
price="1.42"
volume="24339.00"
latest_trading_day="2023-08-30"
previous_close="1.43"
change="-0.01"
change_percent="-0.6993%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="41"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="186422"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="1134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_negative_thumbnail_id_2="1154"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0188.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="951"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
